Literature DB >> 31502960

Prediction of Upstaged Ductal Carcinoma In Situ Using Forced Labeling and Domain Adaptation.

Rui Hou, Maciej A Mazurowski, Lars J Grimm, Jeffrey R Marks, Lorraine M King, Carlo C Maley, Eun-Sil Shelley Hwang, Joseph Y Lo.   

Abstract

OBJECTIVE: The goal of this study is to use adjunctive classes to improve a predictive model whose performance is limited by the common problems of small numbers of primary cases, high feature dimensionality, and poor class separability. Specifically, our clinical task is to use mammographic features to predict whether ductal carcinoma in situ (DCIS) identified at needle core biopsy will be later upstaged or shown to contain invasive breast cancer.
METHODS: To improve the prediction of pure DCIS (negative) versus upstaged DCIS (positive) cases, this study considers the adjunctive roles of two related classes: atypical ductal hyperplasia (ADH), a non-cancer type of breast abnormity, and invasive ductal carcinoma (IDC), with 113 computer vision based mammographic features extracted from each case. To improve the baseline Model A's classification of pure vs. upstaged DCIS, we designed three different strategies (Models B, C, D) with different ways of embedding features or inputs.
RESULTS: Based on ROC analysis, the baseline Model A performed with AUC of 0.614 (95% CI, 0.496-0.733). All three new models performed better than the baseline, with domain adaptation (Model D) performing the best with an AUC of 0.697 (95% CI, 0.595-0.797).
CONCLUSION: We improved the prediction performance of DCIS upstaging by embedding two related pathology classes in different training phases. SIGNIFICANCE: The three new strategies of embedding related class data all outperformed the baseline model, thus demonstrating not only feature similarities among these different classes, but also the potential for improving classification by using other related classes.

Entities:  

Mesh:

Year:  2019        PMID: 31502960      PMCID: PMC7757748          DOI: 10.1109/TBME.2019.2940195

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  23 in total

1.  Predicting invasion in mammographically detected microcalcification.

Authors:  M J Bagnall; A J Evans; A R Wilson; S E Pinder; H Denley; J G Geraghty; I O Ellis
Journal:  Clin Radiol       Date:  2001-10       Impact factor: 2.350

2.  Surveillance of BIRADS 3 lesions.

Authors:  Syed Zama Ali
Journal:  Breast J       Date:  2017-06-27       Impact factor: 2.431

3.  Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?

Authors:  Bibo Shi; Lars J Grimm; Maciej A Mazurowski; Jay A Baker; Jeffrey R Marks; Lorraine M King; Carlo C Maley; E Shelley Hwang; Joseph Y Lo
Journal:  Acad Radiol       Date:  2017-05-11       Impact factor: 3.173

4.  Deep learning analysis of breast MRIs for prediction of occult invasive disease in ductal carcinoma in situ.

Authors:  Zhe Zhu; Michael Harowicz; Jun Zhang; Ashirbani Saha; Lars J Grimm; E Shelley Hwang; Maciej A Mazurowski
Journal:  Comput Biol Med       Date:  2019-10-16       Impact factor: 4.589

5.  The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.

Authors:  Melinda E Sanders; Peggy A Schuyler; William D Dupont; David L Page
Journal:  Cancer       Date:  2005-06-15       Impact factor: 6.860

Review 6.  Ductal carcinoma in situ: terminology, classification, and natural history.

Authors:  D Craig Allred
Journal:  J Natl Cancer Inst Monogr       Date:  2010

7.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

8.  Recent trends in breast cancer among younger women in the United States.

Authors:  Louise A Brinton; Mark E Sherman; J Daniel Carreon; William F Anderson
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

9.  Scoring by nonlocal image patch estimator for early detection of Alzheimer's disease.

Authors:  Pierrick Coupé; Simon F Eskildsen; José V Manjón; Vladimir S Fonov; Jens C Pruessner; Michèle Allard; D Louis Collins
Journal:  Neuroimage Clin       Date:  2012-10-17       Impact factor: 4.881

10.  Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.

Authors:  Xiao Da; Jon B Toledo; Jarcy Zee; David A Wolk; Sharon X Xie; Yangming Ou; Amanda Shacklett; Paraskevi Parmpi; Leslie Shaw; John Q Trojanowski; Christos Davatzikos
Journal:  Neuroimage Clin       Date:  2013-11-28       Impact factor: 4.881

View more
  3 in total

Review 1.  Learning to distinguish progressive and non-progressive ductal carcinoma in situ.

Authors:  Anna K Casasent; Mathilde M Almekinders; Charlotta Mulder; Proteeti Bhattacharjee; Deborah Collyar; Alastair M Thompson; Jos Jonkers; Esther H Lips; Jacco van Rheenen; E Shelley Hwang; Serena Nik-Zainal; Nicholas E Navin; Jelle Wesseling
Journal:  Nat Rev Cancer       Date:  2022-10-19       Impact factor: 69.800

2.  Prediction of Upstaging in Ductal Carcinoma in Situ Based on Mammographic Radiomic Features.

Authors:  Rui Hou; Lars J Grimm; Maciej A Mazurowski; Jeffrey R Marks; Lorraine M King; Carlo C Maley; Thomas Lynch; Marja van Oirsouw; Keith Rogers; Nicholas Stone; Matthew Wallis; Jonas Teuwen; Jelle Wesseling; E Shelley Hwang; Joseph Y Lo
Journal:  Radiology       Date:  2022-01-04       Impact factor: 29.146

3.  Analysis of Signs and Effects of Surgical Breast Cancer Patients Based on Big Data Technology.

Authors:  Zhen Hong; Qin Xu; Xin Yan; Ran Zhang; Yuanfang Ren; Qian Tong
Journal:  Comput Intell Neurosci       Date:  2022-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.